NCT01997879View on ClinicalTrials.gov

Study Assessing Ocular and Systemic Safety of AR-13324 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Healthy
Interventions
DRUG

AR-13324 Ophthalmic Solution, 0.02%

Eyedrop

Trial Locations (1)

85283

Celerion, Phoenix

Sponsors
All Listed Sponsors
lead

Aerie Pharmaceuticals

INDUSTRY

NCT01997879 - Study Assessing Ocular and Systemic Safety of AR-13324 in Healthy Volunteers | Biotech Hunter | Biotech Hunter